DUBLIN — April 9, 2018 — Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension).

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

The American Heart Association and VIVA Physicians, Inc. announced today a two-year $1 million grant program to support research initiatives in vascular disease and career development opportunities for early career investigators at the post-doctoral level.

Patients hospitalized with acute myocardial infarction (AMI) actually fare better when some of the top minds in interventional cardiology are away at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting, suggests a study published March 9 in the Journal of the American Heart Association.

In 2017, Anthem implemented a new policy that requires outpatient MR and CT scans not considered medically necessary to be completed at a freestanding imaging facility to receive coverage. This went into effect in several states, sparking its fair share of controversy along the way, and a team of Boston-based researchers wanted to know how such a policy could impact patient care in Massachusetts.

REDWOOD CITY, Calif., March 1, 2018 — HeartFlow, Inc. today announced that it has entered into a licensing and technology transfer agreement with Cedars-Sinai in Los Angeles for AutoPlaque technology, a software tool used to detect and characterize coronary artery plaque based on coronary computed tomography angiography (CCTA) images.

Could the ORBITA trial’s enduring value be in prompting the cardiology community to rethink how it diagnoses, treats and even defines angina?

The American Society of Echocardiography (ASE) announced Jan. 29 its ImageGuideEcho registry is open to U.S. physicians. ImageGuideEcho is the first registry exclusively devoted to measuring quality in cardiovascular ultrasounds.